In this profile for CBS News Central, watch cancer survivor Sue Service share her story of battling HER2+ breast cancer and the benefits of the targeted treatment Herceptin, developed by Jonsson Comprehensive Cancer Center's Dennis Slamon and his "dream team" of cancer researchers.

Watch the video.